Bio-Techne Corporation has launched Cultrex™ Synthetic Hydrogel, a fully defined synthetic extracellular matrix (ECM) designed to enhance reproducibility and standardization in 3D stem cell and organoid research.
The new product expands the company’s established Cultrex ECM portfolio by providing a synthetic alternative to traditional, animal-derived matrices, reducing lot-to-lot variability while supporting scalable and regulatory-aligned workflows.
Cultrex Synthetic Hydrogel is tailored for use in a wide range of applications, including drug screening, toxicology, and personalized medicine. By eliminating the biological variability inherent in conventional ECMs, the hydrogel enables more consistent experimental conditions across studies and laboratories, supporting reproducible organoid culture.
The product aligns with regulatory trends promoting new approach methodologies (NAMs) and translational research, offering traceable and controlled composition suitable for preclinical studies. Its launch represents a step toward broader adoption of organoid models in research programs moving from discovery to regulatory-facing workflows.
This synthetic ECM complements Bio-Techne’s existing portfolio of tools for stem cell and organoid culture, which includes Cultrex Basement Membrane Extracts (BME), recombinant cytokines and growth factors, AI-modified proteins, small molecules, media, and supplements. Together, these solutions provide researchers with scalable, standardized, and flexible options to meet experimental and regulatory requirements.
The launch underscores Bio-Techne’s focus on supporting reproducible and reliable 3D culture systems for advanced biomedical research.
